Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Pancreatic Cancer · Gastric Cancer · Gastrointestinal Cancer · Colon Cancer · Rectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center) · irc@nih.gov · 866-820-4505
Study leads
James C Yang, M.D.
Principal Investigator
National Cancer Institute (NCI)